Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Akari Therapeutics, Plc (AKTX) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Akari Therapeutics, Plc (AKTX), most recent 12 months reported: net loss $30.96M. Latest balance sheet on file: liquid cash $7.69M, total debt $693K, net cash $7M. From SEC filings. More on Akari Therapeutics, Plc: Profitability · Cash flow · Debt Others in Pharmaceutical Preparations: ACCUSTEM SCIENCES, INC. · Acurx Pharmaceuticals, Inc. · ADIAL PHARMACEUTICALS, INC. · AEON Biopharma, Inc. · ALDEYRA THERAPEUTICS, INC. · ALX ONCOLOGY HOLDINGS INC · ALZAMEND NEURO, INC. · Amylyx Pharmaceuticals, Inc.

Stock screener

Watchlist